Literature DB >> 20610725

7SL RNA is retained in HIV-1 minimal virus-like particles as an S-domain fragment.

Sarra E Keene1, Steven R King, Alice Telesnitsky.   

Abstract

HIV-1 is known to package several small cellular RNAs in addition to its genome. Previous work consistently demonstrated that the host structural RNA 7SL is abundant in HIV-1 virions but has yielded conflicting results regarding whether 7SL is present in minimal, assembly-competent virus-like particles (VLPs). Here, we demonstrate that minimal HIV-1 VLPs retain 7SL RNA primarily as an endoribonucleolytic fragment, referred to as 7SL remnant (7SLrem). Nuclease mapping showed that 7SLrem is a 111-nucleotide internal portion of 7SL, with 5' and 3' ends corresponding to unpaired loops in the 7SL two-dimensional structure. Analysis of VLPs comprised of different subsets of Gag domains revealed that all NC-positive VLPs contained intact 7SL while the presence of 7SLrem correlated with the absence of the NC domain. Because 7SLrem, which maps to the 7SL S domain, was not detectable in infected cells, we propose a model whereby the species recruited to assembling VLPs is intact 7SL RNA, with 7SLrem produced by an endoribonuclease in the absence of NC. Since recruitment of 7SL RNA was a conserved feature of all tested minimal VLPs, our model further suggests that 7SL's recruitment is mediated, either directly or indirectly, through interactions with conserved features of all tested VLPs, such as the C-terminal domain of CA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610725      PMCID: PMC2937644          DOI: 10.1128/JVI.00714-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.

Authors:  Tao Wang; Chunjuan Tian; Wenyan Zhang; Phuong Thi Nguyen Sarkis; Xiao-Fang Yu
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

Review 2.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

Review 3.  Delivering proteins for export from the cytosol.

Authors:  Benedict C S Cross; Irmgard Sinning; Joen Luirink; Stephen High
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

4.  Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly.

Authors:  Rachael M Crist; Siddhartha A K Datta; Andrew G Stephen; Ferri Soheilian; Jane Mirro; Robert J Fisher; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

5.  Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription.

Authors:  James A Thomas; William J Bosche; Teresa L Shatzer; Donald G Johnson; Robert J Gorelick
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.

Authors:  Tao Wang; Wenyan Zhang; Chunjuan Tian; Bindong Liu; Yunkai Yu; Lingmei Ding; Paul Spearman; Xiao-Fang Yu
Journal:  Virology       Date:  2008-05-21       Impact factor: 3.616

Review 8.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

Review 9.  When is it time for reverse transcription to start and go?

Authors:  Marylène Mougel; Laurent Houzet; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2009-03-04       Impact factor: 4.602

10.  Characterization of APOBEC3G binding to 7SL RNA.

Authors:  Daniel Bach; Shyam Peddi; Bastien Mangeat; Asvin Lakkaraju; Katharina Strub; Didier Trono
Journal:  Retrovirology       Date:  2008-07-02       Impact factor: 4.602

View more
  26 in total

1.  Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

Authors:  Wenyan Zhang; Juan Du; Kevin Yu; Tao Wang; Xiong Yong; Xiao-Fang Yu
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  cis-Acting determinants of 7SL RNA packaging by HIV-1.

Authors:  Sarra E Keene; Alice Telesnitsky
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 3.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

4.  Functional redundancy in HIV-1 viral particle assembly.

Authors:  Ina P O'Carroll; Rachael M Crist; Jane Mirro; Demetria Harvin; Ferri Soheilian; Anne Kamata; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

5.  Influence of gag and RRE Sequences on HIV-1 RNA Packaging Signal Structure and Function.

Authors:  Siarhei Kharytonchyk; Joshua D Brown; Krista Stilger; Saif Yasin; Aishwarya S Iyer; John Collins; Michael F Summers; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2018-05-19       Impact factor: 5.469

6.  Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein.

Authors:  Silas F Johnson; Eric L Garcia; Michael F Summers; Alice Telesnitsky
Journal:  Virology       Date:  2012-05-25       Impact factor: 3.616

7.  GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.

Authors:  Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mohammed Mansour Abbas Eid; Mayuko Shimoda; Terumasa Ikeda; Atsushi Koito; Phuong Pham; Myron F Goodman; Nobuo Sakaguchi
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

8.  Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.

Authors:  Silas F Johnson; John T Collins; Victoria M D'Souza; Alice Telesnitsky
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9.

Authors:  Andrea R Beyer; Darrin V Bann; Breanna Rice; Ingrid S Pultz; Melissa Kane; Stephen P Goff; Tatyana V Golovkina; Leslie J Parent
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 10.  SRPassing Co-translational Targeting: The Role of the Signal Recognition Particle in Protein Targeting and mRNA Protection.

Authors:  Morgana K Kellogg; Sarah C Miller; Elena B Tikhonova; Andrey L Karamyshev
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.